Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Market Cap $3.068M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PLG | Ann: Quarterly Activities/Appendix 5B Cash Flow Report | 17:46 | 0 | 391 | |||
|
|||||||
PLG | Ann: Half Year Financial Report - 31 December 2024 | 11/03/25 | 0 | 267 | |||
|
|||||||
PLG | Ann: Quarterly Activities/Appendix 5B Cash Flow Report | 31/01/25 | 0 | 429 | |||
|
|||||||
PLG | Ann: Results of Annual General Meeting | 21/11/24 | 0 | 384 | |||
|
|||||||
PLG | Ann: Quarterly Activities/Appendix 5B Cash Flow Report | 31/10/24 | 0 | 506 | |||
|
|||||||
PLG | Ann: Letter to Shareholders regarding Notice of AGM | 22/10/24 | 0 | 407 | |||
|
|||||||
PLG | Ann: Notice of Annual General Meeting/Proxy Form | 22/10/24 | 0 | 454 | |||
|
|||||||
PLG | Ann: 2024 Annual General Meeting - Key Dates | 26/09/24 | 0 | 458 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |